Liu Limin, Li Nan, Zhao Zhen, Li Wei, Xia Weibo
Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, DonDanSanTiao Street, 100730 Beijing, China; Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, North LiShi Road, 100037 Beijing, China.
Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, DonDanSanTiao Street, 100730 Beijing, China; Department of Geriatric Endocrinology, Chinese PLA General Hospital, FuXing Road, 100853, Beijing, China.
Joint Bone Spine. 2015 Mar;82(2):125-8. doi: 10.1016/j.jbspin.2014.10.005. Epub 2014 Dec 29.
Spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA) is an autosomal recessive skeletal disorder resulting from pathogenic mutations in the Wnt1-inducible signaling pathway protein 3 (WISP3) gene. This disorder predominantly involves the skeletal system, with the leading features of platyspondyly, metaphyseal dysplasia of limbs and extremities, and progressive degeneration of joints. To date, 53 distinct forms of WISP3 mutations have been detected globally, eleven of which originated from Chinese patients. In the current study, we reported the clinical manifestations and radiographic features of two unrelated Chinese SEDT-PA patients. Through genetic analysis, two novel mutations (c.624delA, c.105dupT) as well as one recurrent mutation (c.342T>G) were identified in the WISP3 gene. Our study contributed to the further expansion of the WISP3 mutation spectrum, and demonstrated the genotype-phenotype relationship between mutations in the WISP3 gene and clinical findings of SEDT-PA.
迟发性脊椎骨骺发育不良伴进行性关节病(SEDT-PA)是一种常染色体隐性遗传性骨骼疾病,由Wnt1诱导信号通路蛋白3(WISP3)基因的致病性突变引起。这种疾病主要累及骨骼系统,主要特征为椎体扁平、四肢干骺端发育不良以及关节进行性退变。迄今为止,全球已检测到53种不同形式的WISP3突变,其中11种来自中国患者。在本研究中,我们报告了两名无血缘关系的中国SEDT-PA患者的临床表现和影像学特征。通过基因分析,在WISP3基因中鉴定出两个新突变(c.624delA、c.105dupT)以及一个重复突变(c.342T>G)。我们的研究有助于进一步扩大WISP3突变谱,并证明了WISP3基因突变与SEDT-PA临床发现之间的基因型-表型关系。